https://www.idival.org/wp-content/uploads/2022/05/cab-presentacion.jpg

Creativity and Health Come Together at the 2025 i-Days, the Innovation Event Driven by IDIVAL

27 de October de 2025

The Marqués de Valdecilla Research Institute (IDIVAL), in collaboration with the University of Cantabria and EIT Health, has held a new edition of the Innovation Days (i-Days), an event that challenges students from different fields to design innovative solutions to real-world problems in the healthcare sector. During the event, participants —from diverse academic backgrounds and […]

Read more →

The joint work of a multidisciplinary team identifies a new accelerated progression phenotype in diffuse idiopathic skeletal hyperostosis

22 de October de 2025

The discovery opens a new line of research into the biology of accelerated ossification A study conducted by a multidisciplinary team composed of researchers from the Immunopathology Group at the Valdecilla Health Research Institute (IDIVAL), led by Drs. Emilio Pariente and José Luis Hernández, together with professionals from the Internal Medicine and Rheumatology Departments of […]

Read more →

October 30, the next session of the Santander Biomedical Lectures program

On Thursday, October 30, the next session of the Santander Biomedical Lectures program will take place. On this occasion, Alexey V. Danilov will deliver a lecture entitled: “Ubiquitin-proteasome system as a therapeutic target in hematologic malignancies.” Alexey V. Danilov earned his medical degree in Russia and completed a hematology/oncology fellowship at Tufts Medical Center in […]

Read more →

IDIVAL Researchers identify a new therapeutic potential against chronic lymphocytic leukemia

20 de October de 2025

A drug combination eliminates up to 80% of cancer cells in preclinical studies without affecting healthy cells A team of researchers from the IDIVAL Health Research Institute and physicians from the Hematology Department of the Marqués de Valdecilla University Hospital has published in the journal Biomedicine & Pharmacotherapy the study titled “Inhibition of NEDDylation enhances […]

Read more →

“El Reto de La Caja” Raises Over 18,000€ for Childhood Cancer Research at IDIVAL

17 de October de 2025

The project, led by Cantabrian illusionists Mago Xuso and Asier Moon, turned the center of Santander into a space for awareness and solidarity. Its goal: to make visible, normalize, and make life easier for children battling cancer The charitable initiative “Tel Reto de la Caja”, promoted by magicians Xuso and Asier Moon, has managed to […]

Read more →

The Digestive System Department of Valdecilla Hospital to celebrate its 50th anniversary with a commemorative event bringing together specialists from across Spain

15 de October de 2025

The Marqués de Valdecilla University Hospital (HUMV) will celebrate the 50th Anniversary of its Digestive System Department on October 24, in an event that will bring together specialists from all over Spain to reflect on half a century of clinical progress, scientific innovation, and commitment to patients. The ceremony will take place in the Gómez […]

Read more →

IDIVAL hosts a conference on administrative simplification in the Cantabrian Public Health System

14 de October de 2025

The Marqués de Valdecilla Research Institute (IDIVAL) will hold a conference on Administrative Simplification next Tuesday, October 22. The event aims to reflect on the progress, challenges, and opportunities offered by the simplification of administrative processes within the region’s public healthcare system. The session, scheduled from 10:00 to 11:30 a.m., will take place in the […]

Read more →

IDIVAL participates in the JACARDI General Assembly, bringing together European countries in Madrid committed to reducing health inequalities

Health equity remains one of Europe’s most pressing challenges. Differences in access to care, diagnosis, and treatment continue to shape health outcomes across the region. Gender is emerging as a particularly critical dimension, as women in Europe face worse outcomes in cardiovascular diseases — from higher mortality after heart attacks to longer delays in receiving […]

Read more →

A breakthrough opens the door to preventing aortic aneurysms without surgery

9 de October de 2025

Dr. J. Francisco Nistal, from the “Marqués de Valdecilla” University Hospital, provides the clinical insight that brings this scientific discovery closer to its future application in patients Researchers from CIBERCV, coordinated by the Severo Ochoa Molecular Biology Center (CBM-CSIC-UAM) and the Health Research Institute Fundación Jiménez Díaz (IIS-FJD), have identified a key mechanism involved in […]

Read more →

An international study questions the routine use of beta-blockers after a heart attack in patients with a residual ejection fraction greater than 50%

8 de October de 2025

The REBOOT trial concludes, published in “The New England Journal of Medicine”, with the participation of Dr. José María de la Torre Hernández, Head of Cardiology at Valdecilla Hospital One of the most widespread practices in modern cardiology—the routine use of beta-blockers after a myocardial infarction—has been called into question thanks to the results of […]

Read more →